Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low Nadir Testosterone in Prostate Cancer Patients

Evidence suggests lower nadir testosterone levels during the first year of androgen deprivation therapy improve advanced prostate cancer clinical outcomes. We evaluated pivotal trials for subcutaneously administered leuprolide acetate (1-, 3-, 4-, and 6-month doses) to determine nadir testosterone l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Rev Urol
Autors principals: Pieczonka, Christopher M., Twardowski, Przemyslaw, Renzulli, Joseph, Hafron, Jason, Boldt-Houle, Deborah M., Atkinson, Stuart, Eggener, Scott
Format: Artigo
Idioma:Inglês
Publicat: MedReviews, LLC 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168320/
https://ncbi.nlm.nih.gov/pubmed/30288142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3909/riu0798
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars